MPP5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.780200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.297800E-01
Normal-vs-Stage2
4.407600E-01
Normal-vs-Stage3
3.439000E-01
Normal-vs-Stage4
2.495800E-01
Stage1-vs-Stage2
9.530800E-01
Stage1-vs-Stage3
1.635200E-01
Stage1-vs-Stage4
4.055200E-01
Stage2-vs-Stage3
9.640000E-02
Stage2-vs-Stage4
2.383800E-01
Stage3-vs-Stage4
7.191800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.820600E-01
Normal-vs-AfricanAmerican
4.395400E-01
Normal-vs-Asian
8.687400E-01
Caucasian-vs-AfricanAmerican
3.844000E-01
Caucasian-vs-Asian
3.149600E-01
AfricanAmerican-vs-Asian
2.650600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.112800E-01
Normal-vs-Female
5.743000E-01
Male-vs-Female
3.255000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.204000E-01
Normal-vs-Age(41-60Yrs)
2.714600E-01
Normal-vs-Age(61-80Yrs)
6.006600E-01
Normal-vs-Age(81-100Yrs)
7.078000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.735400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.583200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.895600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.398200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.885760E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.395000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.612400E-01
Normal-vs-Daily Drinker
8.116200E-01
Normal-vs-Weekly Drinker
8.043400E-01
Normal-vs-Occasional Drinker
1.837790E-01
Normal-vs-Social Drinker
4.035600E-01
Non Drinker-vs-Daily Drinker
7.145800E-01
Non Drinker-vs-Weekly Drinker
8.839200E-01
Non Drinker-vs-Occasional Drinker
4.567600E-02
Non Drinker-vs-Social Drinker
5.749200E-01
Daily Drinker-vs-Weekly Drinker
8.972400E-01
Daily Drinker-vs-Occasional Drinker
3.661900E-02
Daily Drinker-vs-Social Drinker
4.052800E-01
Weekly Drinker-vs-Occasional Drinker
1.222030E-01
Weekly Drinker-vs-Social Drinker
5.958400E-01
Occasional Drinker-vs-Social Drinker
1.786820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.078620E-01
Normal-vs-Grade 2
2.813600E-02
Normal-vs-Grade 3
9.163000E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.586800E-01
Grade 1-vs-Grade 3
2.412200E-02
Grade 1-vs-Grade 4
1.078620E-01
Grade 2-vs-Grade 3
8.504300E-02
Grade 2-vs-Grade 4
2.813600E-02
Grade 3-vs-Grade 4
9.163000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.240600E-01
Normal-vs-NonDiabetic
4.707000E-01
Diabetic-vs-NonDiabetic
3.969000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.827000E-01
Normal-vs-NoPancreatitis
5.004400E-01
Pancreatitis-vs-NoPancreatitis
2.725000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.110600E-01
Normal-vs-N1
4.209800E-01
N0-vs-N1
3.090600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.204250E-01
Normal-vs-TP53-NonMutant
4.473600E-01
TP53-Mutant-vs-TP53-NonMutant
2.578200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
